TABLE 5.
Genome region | Nucleotide (amino acid) mutation | Known or assumed biological relevance (figure or reference) |
---|---|---|
5′ UTR | U156→C | Stabilization of domain II structure (Fig. 1A) |
U398→C | Stabilization of domain IV structure (Fig. 1B) | |
A481→G | Deattenuation (41) | |
VP2 | A1429→G (S159→G) | Region of antigenic site 2 (32) |
G1462→A (A170→T) | Antigenic site 2 (45) | |
A1468→G (N172→D) | Antigenic site 2 (45) | |
VP3 | A1997→G (H77→R) | Antigenic site 3b (45) |
C1998→A (H77→Q) | Antigenic site 3b (45) | |
A2005→G (T80→A) | Antigenic site 3b (45) | |
VP1 | U2909→C (I143→T) | Deattenuation (41) |
G3343→A (D288→N) | Antigenic site 3 (45) | |
3C | G5949→A | Stabilization of ciRNA structure (Fig. 1D) |
3′ UTR | G7405→A | Stabilization of oriR structure (Fig. 1C) |